Amarin Corporation plc (AMRN) is in Healthcare, Drug Manufacturers - General, based in Ireland, listed on NasdaqCM. Market cap 251.42M USD. 52-week range 11.83 to 20.90 USD. Data as of 2026-10-09.
Amarin Corporation plc, a pharmaceutical company, engages in the commercialization and development of therapeutics for the treatment of cardiovascular diseases in the United States, Europe, and internationally. It offers VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. The company sells its products principally through wholesalers, selected regional wholesalers, and retail and ...